Russell Beyer

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Preventice Technologies, Inc. develops mobile health and wellness platform solutions. It designs monitoring systems, uses the latest in cloud, analytical, and micro-electronic technology to connect patients to their doctors and healthcare providers. The company was founded in 2007 and is headquartered in Minneapolis, MN.

PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA.

Biscayne Pharmaceuticals, Inc. develops drugs and pharmaceutical products. It offers drugs for CNS disorders such as refractory epilepsy and drug-resistant cancer. The firm also provides cancer therapies that block growth hormone-releasing hormone (GHRH) receptors. The company was founded by Andrew V. Schally and Samuel J. Reich in 2012 and is headquartered in Miami, FL.

Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania.

Part of MeritCare Health System, Hematech, Inc. develops pharmaceutical products. The company is based in Sioux Falls, SD. Hematech was acquired by Sanford Health Corp. from Kirin Holdings Co., Ltd. on December 31, 2012.

Excel Medical Ventures LLC (Excel Medical Ventures) is a venture capital firm founded in 2004 by Steven R. Gullans. The firm is headquartered in Boston, Massachusetts.

EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia.

Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Bureau of Medicine & Surgery operates medical clinics and offices of physicians.

Ginkgo Bioworks, Inc. engages in the development of microbe for different applications. Its organisms can be used for fuels, flavorings, fragrances, cosmetics, and pharmaceutical products. The company was founded by Thomas F. Knight Jr., Austin Che, Reshma Shetty, Bartholomew Canton and Jason Kelly in 2008 and is headquartered in Boston, MA.

PrescribeWell, Inc. provides an online health management system. It offers health care practitioners, physicians and obesity intervention business. The company was founded by Shahid Shah, Amir Jafri, Mervyn J. Turner, Merv Heller and Susan Schramm-Apple in 2014 and is headquartered in Hatfield, PA.

Bridge Medicines LLC operates as a drug discovery company. It provides spanning therapeutic areas including infectious disease, oncology, neuropsychiatry, and rare diseases. The company was founded on November 1, 2016 and is headquartered in New York, NY.

Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA.

This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then.

Lunac Therapeutics Ltd. engages in the identification and development of anticoagulants. The company was founded by Helen Philippou and Richard Foster on April 18, 2018 and is headquartered in Leeds, the United Kingdom.

AMI Expeditionary Healthcare LLC is a physician-owned and physician-led company that provides medical services to private sector, government agencies, international aid organizations, and humanitarian concerns in remote and challenging environments. The company is based in Reston, VA and has subsidiaries in Malta. The company has delivered healthcare solutions to over 140 clinical and hospital settings on four continents. AMI offers flexible, adaptable, and scalable healthcare solutions to clients and communities in need across the globe. The CEO of the company is Andrew Walker.

Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals, Inc. is a leading pharmaceutical company that has been developing and producing medicines for over a century. Teva Pharmaceuticals is based in Parsippany, NJ. The company is a leader in generic and innovative medicines, with a portfolio of over 3,500 products in nearly every therapeutic area. Teva serves around 200 million people worldwide, and has one of the largest and most complex supply chains in the pharmaceutical industry. The company has a significant presence in both generics and innovative medicines research and operations, supporting its growing portfolio of innovative medicines and biopharmaceutical products.